Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Lyko V."'
Autor:
Pepin S., Nicolas J. -F., Szymanski H., Leroux-Roels I., Schaum T., Bonten M., Icardi G., Shrestha A., Tabar C., Van Damme P., Donazzolo Y., Launay O., Schurholz T., Sturm K., Toursarkissian N., Schenkenberger I., Vitale F., Brzostek J., Pajek B., Miszczak-Kowalska E., Khoury R., Grosbois M. -A., Gauby C., Lacroix I., Souzy F., Pandey A., Yandle S., Lupinsky N., Goulet F., Milcamps L., De Sousa J., Lardon M., Lyko V., Blattmann A., Janosczyk H., Samson S., De Bruijn I.
Publikováno v:
HUMAN VACCINES & IMMUNOTHERAPEUTICS
A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults ≥65y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been evaluated in adults aged 60–64y. This study compared immunogenicity an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdf0c49a65fbdbcf7d14b4935d9b244
https://pubmed.ncbi.nlm.nih.gov/35674507
https://pubmed.ncbi.nlm.nih.gov/35674507
